Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment

Published:2024-07-04 Issue:14 Volume:67 Page:12314-12330
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Min Wenjian¹²³,Yang Huanaoyu¹²³,Wang Dawei¹²³,Chen Chunling¹²³,Wang Yanyin¹²³,Hou Yi¹²³,Zhu Yasheng¹²³,Sun Chengliang¹²³,Wang Xiao¹²³,Yuan Kai¹²³^ORCID,Yang Peng¹²³^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China

2. Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China

3. Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, Nanjing 211198, China

Funder

Jiangsu Planned Projects for Postdoctoral Research Funds

National Key Research and Development Program of China

State Key Laboratory of Natural Medicines

China Postdoctoral Science Foundation

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c01004

Reference32 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Epidemiology and Management of Hepatocellular Carcinoma

5. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP